Chronic Urticaria
- 1 December 2022
- journal article
- letter
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 387 (22), 2101-2103
- https://doi.org/10.1056/nejmc2212742
Abstract
To the Editor: With respect to the review article on chronic urticaria by Lang (Sept. 1 issue),1 angioedema may be of special interest. Bradykinin-mediated angioedema was not addressed in the review. This rare chronic hereditary urticaria mediated by bradykinin may be life-threatening, and treatments for this condition have been developed.2 Clinicians may also see angiotensin-converting–enzyme (ACE) inhibitor–induced angioedema that does not respond to treatment with antihistamines and glucocorticoids. To the Editor: In the review article on chronic urticaria, Figure 3 describes stepped care. The author states that the information in this figure was synthesized from recommendations based on clinical guidelines. . . .This publication has 17 references indexed in Scilit:
- Another look at cyclosporine for treating antihistamine-resistant chronic spontaneous urticariaAnnals of Allergy, Asthma & Immunology, 2019
- IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticariaJournal of Allergy and Clinical Immunology, 2018
- Cyclosporine for Chronic Spontaneous Urticaria: A Meta-Analysis and Systematic ReviewThe Journal of Allergy and Clinical Immunology: In Practice, 2018
- Treatment of Chronic Urticaria in Children with Antihistamines and CyclosporineThe Journal of Allergy and Clinical Immunology: In Practice, 2014
- The diagnosis and management of acute and chronic urticaria: 2014 updateJournal of Allergy and Clinical Immunology, 2014
- Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous UrticariaThe New England Journal of Medicine, 2013
- Experience with Cyclosporine in Children with Chronic Idiopathic UrticariaPediatric Dermatology, 2009
- Antileukotrienes in chronic urticariaJournal of Allergy and Clinical Immunology, 1998
- Autoantibodies against the High-Affinity IgE Receptor as a Cause of Histamine Release in Chronic UrticariaThe New England Journal of Medicine, 1993
- Treatment of chronic idiopathic urticaria with combined HI and H2 blockersClinical & Experimental Allergy, 1978